Evidence map›Paper›PMID 38225276›Full record

ReviewNature reviews. Immunology2024

Novel insights into the immune response to bacterial T cell superantigens.

Stephen W Tuffs, Karine Dufresne, Aanchal Rishi, Nicholas R Walton, John K McCormick

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Selective Expansion of TCR Vβ2Experimental dermatology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. GUTAID: a curated database linking gut microbial antigens to autoimmune mechanisms.Database : the journal of biological databases and curation · 2026
    Article
  8. [Research progress on toxic shock syndrome due to group AZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TSST-1 promotes colonization ofInfection and immunity · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephen W TuffsDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.ORCID http://orcid.org/0000-0002-2874-7822
Karine DufresneDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.ORCID http://orcid.org/0000-0001-9423-2037
Aanchal RishiDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.ORCID http://orcid.org/0009-0000-3855-0049
Nicholas R WaltonDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.ORCID http://orcid.org/0009-0006-5345-4550
John K McCormickDepartment of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. john.mccormick@uwo.ca.ORCID http://orcid.org/0000-0003-3742-7289
Western University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial T cell superantigens (SAgs) are a family of microbial exotoxins that function to activate large numbers of T cells simultaneously. SAgs activate T cells by direct binding and crosslinking of the lateral regions of MHC class II molecules on antigen-presenting cells with T cell receptors (TCRs) on T cells; these interactions alter the normal TCR-peptide-MHC class II architecture to activate T cells in a manner that is independent of the antigen specificity of the TCR. SAgs have well-recognized, central roles in human diseases such as toxic shock syndrome and scarlet fever through their quantitative effects on the T cell response; in addition, numerous other consequences of SAg-driven T cell activation are now being recognized, including direct roles in the pathogenesis of endocarditis, bloodstream infections, skin disease and pharyngitis. In this Review, we summarize the expanding family of bacterial SAgs and how these toxins can engage highly diverse adaptive immune receptors. We highlight recent findings regarding how SAg-driven manipulation of the adaptive immune response may operate in multiple human diseases, as well as contributing to the biology and life cycle of SAg-producing bacterial pathogens.

Indexed as

Receptors, Antigen, T-CellSuperantigensT-LymphocytesAnimalsAntigens, BacterialBacteriaHistocompatibility Antigens Class IIHumansLymphocyte ActivationAntigens, BacterialHistocompatibility Antigens Class IIReceptors, Antigen, T-CellSuperantigens

Identifiers

PMID38225276
OpenAlexW4390877197

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.